Autores
Héctor Bueno, Amadeo Betriu, Magda Heras, Joaquín J Alonso, Angel Cequier, Eulogio J García, Jose L Lopez-Sendon, Carlos Macaya, Rosana Hernández-Antolín, TRIANA Investigators, Héctor Bueno, Rosana Hernández-Antolín, Joaquín J Alonso, Amadeo Betriu, Angel Cequier, Eulogio J García, Magda Heras, José L López-Sendón, Carlos Macaya, José Azpitarte, Ginés Sanz, Angel Chamorro, Ramón López-Palop, Alex Sionis, Fernando Arós, Eulogio García-Fernández, Rafael Rubio, Felipe Hernández, Juan Carlos Tascón, José Moreu, Amadeu Betriu, Magda Heras, Rosana Hernández-Antolín, Antonio Fernández-Ortiz, César Morís, Ignacio Sánchez de Posada, Ángel Cequier, Enrique Esplugas, Rafael Melgares, Francisco Bosa, Martín Jesús García-González, Román Lezáun, José Ramón Carmona, José Manuel Vázquez, Alfonso Castro-Beiras, Joan García Picart, José Domínguez de Rozas, José Díaz Fernández, Felipe Fernández Vázquez, Norberto Alonso, José Javier Zueco, José María San José, Alberto San Román, Carolina Hernández, José María Hernández García, Ángel García Alcántara, Armando Bethencourt, Miquel Fiol, Xabier Mancisidor, Xabier Mancisidor, Rafael Ruiz, Rafael Hidalgo, Nicolás Sobrino, Isidoro González Maqueda, Alfonso Torres, Fernando Arós, Antonio Amaro, Michel Jaquet
Fecha de publicación
2011/1/1
Revista
European heart journal
Volumen
32
Número
1
Páginas
51-60
Editor
Oxford University Press
Descripción
Aims
To compare primary percutaneous coronary intervention (pPCI) and fibrinolysis in very old patients with ST-segment elevation myocardial infarction (STEMI), in whom head-to-head comparisons between both strategies are scarce.
Methods and results
Patients ≥75 years old with STEMI <6 h were randomized to pPCI or fibrinolysis. The primary endpoint was a composite of all-cause mortality, re-infarction, or disabling stroke at 30 days. The trial was prematurely stopped due to slow recruitment after enroling 266 patients (134 allocated to pPCI and 132 to fibrinolysis). Both groups were well balanced in baseline characteristics. Mean age was 81 years. The primary endpoint was reached in 25 patients in the pPCI group (18.9%) and 34 (25.4%) in the fibrinolysis arm [odds ratio (OR), 0.69; 95% confidence interval (CI) 0.38–1.23; P = 0.21]. Similarly, non-significant reductions …
Artículos de Google Académico
H Bueno, A Betriu, M Heras, JJ Alonso, A Cequier… - European heart journal, 2011
